Natera Inc
NTRA
NASDAQ
Biotechnology
$309.93
USD
-0.85 (-0.27%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $44.64B
Volume 1.3M
Revenue
$2.71B
TTM
+37.8%
YoY
Gross Margin
65%
TTM
+3.8%
YoY
Net Income
$-192.35M
TTM
+24.0%
YoY
Operating Cash Flow
$228.24M
TTM
+22.2%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 546.6 | 592.2 | 665.5 | 696.6 | 752.8 |
YoY Growth | +32.2% | +34.7% | +39.8% | +38.8% | +37.7% |
Cost of Revenue | 200.0 | 207.8 | 220.1 | 245.8 | 267.6 |
Gross Profit | 346.6 | 384.4 | 445.4 | 450.8 | 485.2 |
Selling, General & Administrative | 310.5 | 308.5 | 291.3 | 327.9 | 327.2 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 457.0 | 482.0 | 468.2 | 544.3 | 561.0 |
Operating Income | -110.4 | -97.6 | -22.8 | -93.5 | -75.8 |
EBITDA | -100.5 | -87.3 | -10.4 | -73.3 | -54.6 |
Other Income / Expense | 10.7 | 0.0 | 0.0 | 9.6 | 9.5 |
Total Other Income / Expense | 9.7 | 10.2 | 9.5 | 8.7 | 8.6 |
Income Before Income Taxes | -100.7 | -87.3 | -13.3 | -84.8 | -67.2 |
Income Taxes | 0.3 | 0.2 | -60.6 | 0.3 | -0.3 |
Net Income | -100.9 | -87.5 | 47.3 | -85.1 | -67.0 |
Consolidated Net Income / Loss | -100.9 | -87.5 | 47.3 | -85.1 | -67.0 |
Net Income Attributable to Common Shareholders | -100.9 | -87.4 | 47.1 | -85.1 | -67.0 |
Basic EPS | -$0.74 | -$0.64 | $0.34 | -$0.60 | -$0.47 |
Diluted EPS | -$0.74 | -$0.64 | $0.34 | -$0.60 | -$0.47 |
Basic Shares Outstanding | 136.4M | 137.2M | 138.6M | 141.5M | 143.3M |
Diluted Shares Outstanding | 136.4M | 137.2M | 138.6M | 141.5M | 143.3M |